<DOC>
	<DOCNO>NCT01282450</DOCNO>
	<brief_summary>In recent year , become clear , also non-small cell lung cancer ( NSCLC ) , group patient less 5 distant metastasis may experience long-term survival treat radically macroscopic cancer site . Thus mostly establish individual so-called solitary brain metastasis lesser extend solitary adrenal gland metastasis , metastatic subgroup , may applicable . In prospective survey region Integral Cancercentre ( IKL ) , could identify yearly base 30 patient NSCLC could theoretically amendable radical treatment oligo-metastatic location . We therefore want perform prospective study patient less 4 oligo-metastatic site primary NSCLC treat radically aim improve long-term survival . As many discussion point remain , even thorough discussion chest physician , pulmonary surgeon colleague diagnostic discipline , decide go pragmatic approach , imply macroscopic disease sit treat radically , define surgery R0 resection case unforeseen R1 resection , follow radiotherapy , radiotherapy biological equivalent least 60 Gy 30 daily fraction . In patient , one metastatic site may treat surgery another radical radiotherapy . Systemic treatment make mandatory , felt 's role unclear patient early stage local cancer oligo-metastatic disease .</brief_summary>
	<brief_title>Concurrent Non-concurrent Chemo-radiotherapy Radiotherapy Alone Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description>Eligible patient ( see ) receive radical radiotherapy primary tumor initially involve mediastinal lymph node MLD ( Mean Lung Dose ) 20 +/- 1Gy , irrespective lung function and/or metastatic site minimal biological equivalent 60Gy 30 daily fraction . This may deliver hypofractionated stereotactic technique protract fractionation regimen . Both primary tumor , regional N1 lymph node oligo-metastatic site ( ) may treat surgery , long R0 resection deem possible . Systemic treatment require , give accord local extend tumor . Local radiotherapy deliver accord protocol MAASTRO clinic anatomical site . Other dose-constraints : spinal cord max : 54Gy , brachial plexus ( Dmax ) : 66Gy The radiation dose specify accord ICRU 50 . Lung density correction apply , well standard QA procedure . Technical requirement standard practice MAASTRO clinic .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Histological cytological proven NSCLC UICC stage IV , solitary metastasis ( &lt; 5 ) , amendable radical local treatment Performance status 02 Other malignancy allow control point diagnosis Not NSCLC mixed NSCLC histology ( e.g . small cell carcinoma ) Stage IIII , except T4 pleural metastasis Performance status 3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>NSCLC</keyword>
</DOC>